Neither long-term statin use nor atherosclerotic disease is associated with risk of colorectal cancer

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 12, 2010, Pages 1056-1061

  Robertson, Douglas J ^a,b   Riis, Anders Hammerich ^c   Friis, Søren ^d   Pedersen, Lars ^c   Baron, John A ^b   Sørensen, Henrik Toft ^c  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

Colorectal Neoplasms; Epidemiology; Hydroxymethylglutaryl CoA Reductase Inhibitors; ICD; Myocardial Infarction

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; HEART INFARCTION; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; STROKE;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CORONARY ARTERY DISEASE; DENMARK; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; RISK ASSESSMENT;

EID: 78649708483     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.08.010     Document Type: Article

References (45)

1. Jemal A., Siegel R., Ward E., et al. Cancer Statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Levin B., Lieberman D.A., McFarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. Gastroenterology 2008, 134:1570-1590. a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.
3. Hawk E., Viner J.L. Statins and cancer -- beyond the "One Drug, One Disease" Model. N Engl J Med 2005, 352:2238-2239.
4. Kauh J., Khuri F.R. Can statins pass the aspirin litmus test in cancer?. J Clin Oncol 2007, 25:3395-3396.
5. Bhuket T.P., Higgins P.D. Drug insight: statins and gastrointestinal cancer. Nat Clin Pract Gastroenterol Hepatol 2006, 3:552-562.
6. de Denus S., Spinler S.A., Miller K., et al. Statins and liver toxicity: a meta-analysis. Pharmacotherapy 2004, 24:584-591.
7. Vasudevan A.R., Hamirani Y.S., Jones P.H. Safety of statins: effects on muscle and the liver. Cleve Clin J Med 2005, 72:990-993. 996-1001.
8. Alberts A.W., Chen J., Kuron G., et al. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A 1980, 77:3957-3961.
9. McKenney J.M. Pharmacologic characteristics of statins. Clin Cardiol 2003, 26:III32-III38.
10. Chan K.K., Oza A.M., Siu L.L. The statins as anticancer agents. Clin Cancer Res 2003, 9:10-19.
11. Rao S., Porter D.C., Chen X., et al. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci U S A 1999, 96:7797-7802.
12. Jain M.K., Ridker P.M. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 2005, 4:977-987.
13. Agarwal B., Rao C.V., Bhendwal S., et al. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology 1999, 117:838-847.
14. Wong W.W., Dimitroulakos J., Minden M.D., et al. HMG-CoA Reductase Inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002, 16:508-519.
15. Poynter J.N., Gruber S.B., Higgins P.D.R., et al. Statins and the risk of colorectal cancer. N Engl J Med 2005, 352:2184-2192.
16. Farwell W.R., Scranton R.E., Lawler E.V., et al. The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst 2008, 100:134-139.
17. Coogan P.F., Smith J., Rosenberg L. Statin use and risk of colorectal cancer. J Natl Cancer Inst 2007, 99:32-40.
18. Vinogradova Y., Hippisley-Cox J., Coupland C., et al. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study. Gastroenterology 2007, 133:393-402.
19. Yang Y.X., Hennessy S., Propert K., et al. Chronic statin therapy and the risk of colorectal cancer. Pharmacoepidemiol Drug Saf 2008, 17:869-876.
20. Correa P., Strong J.P., Johnson W.D., et al. Atherosclerosis and polyps of the colon. Quantification of precursors of coronary heart disease and colon cancer. J Chronic Dis 1982, 35:313-320.
21. Reicher-Reiss H., Jonas M., Goldbourt U., et al. Selectively increased risk of cancer in men with coronary heart disease. Am J Cardiol 2001, 87:459-462. A6.
22. Chan A.O., Jim M.H., Lam K.F., et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA 2007, 298:1412-1419.
23. Friis S., Poulsen A.H., Johnsen S.P., et al. Cancer risk among statin users: a population-based cohort study. Int J Cancer 2005, 114:643-647.
24. Andersen T.F., Madsen M., Jorgensen J., et al. A valuable source of data for modern health sciences. Dan Med Bull 1999, 46:263-268.
25. 8th & 10th Revision of the World Health Organizations Classification of Diseases 1986, Danish National Board of Health, National Board of Health.
26. Szklo M., Nieto F.J. Epidemiology: beyond the basics 2000, Aspen, Gaithersburg, MD.
27. Gaist D., Sorensen H.T., Hallas J. The Danish prescription registries. Dan Med Bull 1997, 44:445-448.
28. Nielsen G.L., Sorensen H.T., Zhou W., et al. The pharmacoepidemiologic prescription database of North Jutland-a valid tool in pharmacoepidemiological research. Int J Risk Saf Med 1997, 10:203-205.
29. Capella D. Descriptive tools and analysis. Drug Utilization Studies. Methods and Uses; Volume European Series. No. 45 1993, 55-78. WHO, Regional Publications, Geneva. M.N.G. Dukes (Ed.).
30. Danish Board of Health. Danish classification of surgical procedures and therapies. 1st, 2nd, 3rd, and 4th eds. Copenhagen, The Netherlands: Danish Board of Health, 1973, 1980, 1988, and 1995.
31. Bellosta S., Paoletti R., Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation 2004, 109:III50-III57.
32. Brown W.V. Safety of statins. Curr Opin Lipidol 2008, 19:558-562.
33. Hachem C., Morgan R., Johnson M., et al. Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol 2009, 104:1241-1248.
34. Dale K.M., Coleman C.I., Henyan N.N., et al. Statins and cancer risk: a meta-analysis. JAMA 2006, 295:74-80.
35. Bonovas S., Filioussi K., Flordellis C.S., et al. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. Clin Oncol J 2007, 25:3462-3468.
36. Duncan R.E., El-Sohemy A., Archer M.C. Statins and cancer development. Cancer Epidemiol Biomarkers Prev 2005, 14:1897-1898.
37. Karp I., Behlouli H., Lelorier J., et al. Statins and cancer risk. Am J Med 2008, 121:302-309.
38. Shepherd J., Blauw G.J., Murphy M.B., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002, 360:1623-1630.
39. Neugut A.I., Rosenberg D.J., Ahsan H., et al. Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev 1998, 7:869-873.
40. Robertson D.J., Larsson H., Friis S., et al. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology 2007, 133:755-760.
41. Thomsen R.W., Johnsen S.P., Olesen A.V., et al. Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol 2005, 60:534-542.
42. Wogelius P., Poulsen S., Sorensen H.T. Validity of parental-reported questionnaire data on Danish children's use of asthma-drugs: a comparison with a population-based prescription database. Eur J Epidemiol 2005, 20:17-22.
43. Lokkegaard E.L., Johnsen S.P., Heitmann B.L., et al. The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand 2004, 83:476-481.
44. Madsen M., Davidsen M., Rasmussen S., et al. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003, 56:124-130.
45. Iversen L.H., Norgaard M., Jepsen P., et al. Trends in colorectal cancer survival in northern Denmark. Colorectal Dis 2007, 9:210-217. 1985-2004.